1
|
Zhai Y, Fu X, Xu W. Miniature mass spectrometers and their potential for clinical point-of-care analysis. MASS SPECTROMETRY REVIEWS 2024; 43:1172-1191. [PMID: 37610153 DOI: 10.1002/mas.21867] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/27/2023] [Revised: 08/04/2023] [Accepted: 08/11/2023] [Indexed: 08/24/2023]
Abstract
Mass spectrometry (MS) has become a powerful technique for clinical applications with high sensitivity and specificity. Different from conventional MS diagnosis in laboratory, point-of-care (POC) analyses in clinics require mass spectrometers and analytical procedures to be friendly for novice users and applicable for on-site clinical diagnosis. The recent decades have seen the progress in the development of miniature mass spectrometers, providing a promising solution for clinical POC applications. In this review, we report recent advances of miniature mass spectrometers and their exploration in clinical applications, mainly including the rapid analysis of illegal drugs, on-site monitoring of therapeutic drugs, and detection of biomarkers. With improved analytical performance, miniature mass spectrometers are also expected to apply to more and more clinical applications. Some promising POC analyses that can be performed by miniature mass spectrometers in the future are discussed. Lastly, we also provide our perspectives on the challenges in technical development of miniature mass spectrometers for clinical POC analysis.
Collapse
Affiliation(s)
- Yanbing Zhai
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Xinyan Fu
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Wei Xu
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| |
Collapse
|
2
|
D’Amato M, Grignano MA, Iadarola P, Rampino T, Gregorini M, Viglio S. The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis. Int J Mol Sci 2024; 25:8633. [PMID: 39201322 PMCID: PMC11354567 DOI: 10.3390/ijms25168633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Revised: 07/19/2024] [Accepted: 08/05/2024] [Indexed: 09/02/2024] Open
Abstract
While COVID-19's urgency has diminished since its emergence in late 2019, it remains a significant public health challenge. Recent research reveals that the molecular intricacies of this virus are far more complex than initially understood, with numerous post-translational modifications leading to diverse proteoforms and viral particle heterogeneity. Mass spectrometry-based proteomics of patient serum/plasma emerges as a promising complementary approach to traditional diagnostic methods, offering insights into SARS-CoV-2 protein dynamics and enhancing understanding of the disease and its long-term consequences. This article highlights key findings from three years of pandemic-era proteomics research. It delves into biomarker discovery, diagnostic advancements, and drug development efforts aimed at monitoring COVID-19 onset and progression and exploring treatment options. Additionally, it examines global protein abundance and post-translational modification profiling to elucidate signaling pathway alterations and protein-protein interactions during infection. Finally, it explores the potential of emerging multi-omics analytic strategies in combatting SARS-CoV-2.
Collapse
Affiliation(s)
- Maura D’Amato
- Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy; (M.D.); (S.V.)
| | - Maria Antonietta Grignano
- Unit of Nephrology, Dialysis and Transplantation, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy; (M.A.G.); (T.R.); (M.G.)
| | - Paolo Iadarola
- Department of Biology and Biotechnologies “L. Spallanzani”, University of Pavia, 27100 Pavia, Italy
| | - Teresa Rampino
- Unit of Nephrology, Dialysis and Transplantation, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy; (M.A.G.); (T.R.); (M.G.)
- Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy
| | - Marilena Gregorini
- Unit of Nephrology, Dialysis and Transplantation, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy; (M.A.G.); (T.R.); (M.G.)
- Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy
| | - Simona Viglio
- Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy; (M.D.); (S.V.)
- Lung Transplantation Unit, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy
| |
Collapse
|
3
|
Fan X, Wu J, Zhang T, Liu J. Electrochemical/Electrochemiluminescence Sensors Based on Vertically-Ordered Mesoporous Silica Films for Biomedical Analytical Applications. Chembiochem 2024:e202400320. [PMID: 38874487 DOI: 10.1002/cbic.202400320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2024] [Revised: 06/04/2024] [Accepted: 06/14/2024] [Indexed: 06/15/2024]
Abstract
Vertically-ordered mesoporous silica films (VMSF, also named as silica isoporous membranes) have shown tremendous potential in the field of electroanalytical sensors due to their unique features in terms of controllable and ultrasmall nanopores, high molecular selectivity and permeability, and mechanical stability. This review will present the recent progress on the biomedical analytical applications of VMSF, focusing on the small biomolecules, diseases-related biomarkers, drugs and cancer cells. Finally, conclusions with recent developments and future perspective of VMSF in the relevant fields will be envisioned.
Collapse
Affiliation(s)
- Xue Fan
- Department of Chemistry, School of Chemistry and Chemical Engineering, Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Zhejiang Sci-Tech University, Hangzhou, 310018, China
| | - Jiayi Wu
- Department of Chemistry, School of Chemistry and Chemical Engineering, Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Zhejiang Sci-Tech University, Hangzhou, 310018, China
| | - Tongtong Zhang
- Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Hangzhou First People's Hospital, Hangzhou, 310006, China
| | - Jiyang Liu
- Department of Chemistry, School of Chemistry and Chemical Engineering, Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Zhejiang Sci-Tech University, Hangzhou, 310018, China
| |
Collapse
|
4
|
Kollhoff L, Kipping M, Rauh M, Ceglarek U, Barka G, Barka F, Sinz A. Development of a rapid and specific MALDI-TOF mass spectrometric assay for SARS-CoV-2 detection. Clin Proteomics 2023; 20:26. [PMID: 37393264 DOI: 10.1186/s12014-023-09415-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 06/19/2023] [Indexed: 07/03/2023] Open
Abstract
We have developed a rapid and highly specific assay for detecting and monitoring SARS-CoV-2 infections by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). As MALDI-TOF mass spectrometers are available in a clinical setting, our assay has the potential to serve as alternative to the commonly used reverse transcriptase quantitative polymerase chain reaction (RT-qPCR). Sample preparation prior to MALDI-TOF-MS involves the tryptic digestion of SARS-CoV-2 proteins, followed by an enrichment of virus-specific peptides from SARS-CoV-2 nucleoprotein via magnetic antibody beads. Our MALDI-TOF-MS method allows the detection of SARS-CoV-2 nucleoprotein in sample collection medium as low as 8 amol/µl. MALDI-TOF mass spectra are obtained in just a few seconds, which makes our MS-based assay suitable for a high-throughput screening of SARS-CoV-2 in healthcare facilities in addition to PCR. Due to the specific detection of virus peptides, different SARS-CoV-2 variants are readily distinguished from each other. Specifically, we show that our MALDI-TOF-MS assay discriminates SARS-CoV-2 strain B.1.617.2 "delta variant" from all other variants in patients' samples, making our method highly valuable to monitor the emergence of new virus variants.
Collapse
Affiliation(s)
- Lydia Kollhoff
- Department of Pharmaceutical Chemistry and Bioanalytics, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany
- Center for Structural Mass Spectrometry, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany
| | - Marc Kipping
- Department of Pharmaceutical Chemistry and Bioanalytics, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany
- Center for Structural Mass Spectrometry, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany
| | - Manfred Rauh
- Department of Pediatrics and Adolescent Medicine, Friedrich Alexander University, Erlangen-Nürnberg, Germany
| | - Uta Ceglarek
- Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Leipzig, Germany
| | - Günes Barka
- SunChrom Wissenschaftliche Geräte GmbH, 61381, Friedrichsdorf, Germany
| | - Frederik Barka
- SunChrom Wissenschaftliche Geräte GmbH, 61381, Friedrichsdorf, Germany
| | - Andrea Sinz
- Department of Pharmaceutical Chemistry and Bioanalytics, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany.
- Center for Structural Mass Spectrometry, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, D-06120, Halle (Saale), Germany.
| |
Collapse
|
5
|
Kukushkin V, Ambartsumyan O, Astrakhantseva A, Gushchin V, Nikonova A, Dorofeeva A, Zverev V, Gambaryan A, Tikhonova D, Sovetnikov T, Akhmetova A, Yaminsky I, Zavyalova E. Lithographic SERS Aptasensor for Ultrasensitive Detection of SARS-CoV-2 in Biological Fluids. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:nano12213854. [PMID: 36364630 PMCID: PMC9659100 DOI: 10.3390/nano12213854] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 10/25/2022] [Accepted: 10/28/2022] [Indexed: 05/27/2023]
Abstract
In this paper, we propose a technology for the rapid and sensitive detection of the whole viral particles of SARS-CoV-2 using double-labeled DNA aptamers as recognition elements together with the SERS method for detecting the optical response. We report on the development of a SERS-aptasensor based on a reproducible lithographic SERS substrate, featuring the combination of high speed, specificity, and ultrasensitive quantitative detection of SARS-CoV-2 virions. The sensor makes it possible to identify SARS-CoV-2 in very low concentrations (the limit of detection was 100 copies/mL), demonstrating a sensitivity level comparable to the existing diagnostic golden standard-the reverse transcription polymerase chain reaction.
Collapse
Affiliation(s)
- Vladimir Kukushkin
- Osipyan Institute of Solid State Physics of Russian Academy of Science, 142432 Chernogolovka, Russia
| | - Oganes Ambartsumyan
- Department of Microbiology, Virology and Immunology, I.M. Sechenov First Moscow State Medical University, 125009 Moscow, Russia
| | - Anna Astrakhantseva
- Osipyan Institute of Solid State Physics of Russian Academy of Science, 142432 Chernogolovka, Russia
- Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia
| | - Vladimir Gushchin
- N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, 123098 Moscow, Russia
| | - Alexandra Nikonova
- Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia
| | | | - Vitaly Zverev
- Department of Microbiology, Virology and Immunology, I.M. Sechenov First Moscow State Medical University, 125009 Moscow, Russia
- Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia
| | - Alexandra Gambaryan
- Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products RAS, 108819 Moscow, Russia
| | - Daria Tikhonova
- Osipyan Institute of Solid State Physics of Russian Academy of Science, 142432 Chernogolovka, Russia
- Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Timofei Sovetnikov
- Faculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Assel Akhmetova
- Faculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Igor Yaminsky
- Faculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Elena Zavyalova
- Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia
| |
Collapse
|